Insiders · Profile

Cohen Neil Harris

Director at Chemomab Therapeutics. Filing since 16 Mar 2021. CIK 0001840006

Company
Date
Role
Action
Shares
Amount
Of holding
28 Aug 2026
Director
Sold at will
1,000
$2.80K
2.9%
27 Aug 2026
Director
Sold at will
1,304
$3.72K
3.7%
16 Nov 2022
Director
Sold, plan not stated
2,409
$4.82K
19.4%
18 May 2022
Director
Bought
2,000
$6.38K
19.2%
14 Mar 2022
Director
Bought
6,000
$26.12K
136%
6 Dec 2021
Director
Bought
2,000
$14.86K
83.0%
16 Mar 2021
Director
Bought
2,409
$100.00K
opened
7 decisions on file.